state Michigan city Ann Arbor hospital death Ventilators patient state Michigan city Ann Arbor

Rheumatoid arthritis drug tied to fewer deaths in COVID patients

Reading now: 848
www.cidrap.umn.edu

Two new studies have revealed that the rheumatoid arthritis drug tocilizumab is associated with lower death rates in COVID-19 patients receiving mechanical ventilation.

Tocilizumab blocks interleukin-6 (IL-6), an inflammatory protein involved in a potential "cytokine storm" that can lead to respiratory failure in coronavirus patients.In the first single-center observational study, published late last week in Clinical Infectious Diseases, University of Michigan at Ann Arbor researchers found that tocilizumab was linked to a 45% reduction in risk of death (hazard ratio [HR], 0.55 (95% confidence interval [CI], 0.33 to 0.90) and improved status after adjusting for propensity score inverse probability weighting (IPTW).In the second study,

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA